Leadership in Nuclear Medicine
Rotem identified the great potential in PET imaging during the early 1990’s, and was the first world-class entity to invest in production of Oxygen-18 enriched water. Thanks to Rotem’s production capacity of this critical raw material, the factor limiting development of PET – FDG availability – was alleviated and the tool spread rapidly into clinical use. Rotem’s O-18 water, sold under the Hyox18 trademark, became recognized as the world standard for quality and reliability.
The close association with cyclotron facilities worldwide set the base for Rotem’s expansion into other consumables necessary for radiotracer synthesis. In 2003 Rotem began supplying FDG precursors manufactured exclusively for it by a second party, and in 2006 this facility was fully acquired and became part of the in-house production operation. In 2005, customers turned to Rotem for supply of disposable cassettes used in the TRACERlab MXFDG synthesis module. This production line was developed quickly, and expanded during 2008 into a state of the art GMP facility. today Rotem’s cassettes are preferred around the world for their high reliability and attractive pricing .
In early 2010 Rotem became fully GMP certified in accordance with ICH / FDA Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
Back to top